Alentejo Accelerator
Evora, Portugal · AcceleratorANJE initiative in southern Portugal providing a 4-month acceleration program with mentoring and business modeling for biotech, agrotech, and ICT startups. Scope: Regional (Alentejo).
A venture fund + angel network based in Szczecin, Pomerangels invests alongside business angels and syndicates in post-revenue companies. With a network of 100+ angels, they co-invest up to €4M in innovative SMEs across ICT, autonomous tech, biotech, etc.
Notable focus: companies that already have strong angel syndicates; Pomerangels adds capital on top of angel rounds to scale these ventures.
Szczecin, Poland
Angel Investor
Seed to Series B
/poland/angel-investor/pomerangels
ANJE initiative in southern Portugal providing a 4-month acceleration program with mentoring and business modeling for biotech, agrotech, and ICT startups. Scope: Regional (Alentejo).
Founded 2009. University-affiliated incubator supporting ICT and biotech startups with a 4-month validation program, follow-on acceleration, labs access, and investor network. Supported 200+ startups including SnappCar. Scope: Regional (Utrecht).
Operator-led Polish deep-tech VC fund with a target size of EUR 20M (about PLN 80M), investing at pre-seed and seed. Founded by Maciej Zawadzinski, Maciej Frankowicz, and Konrad Trzyna, the fund focuses on robotics, photonics, cybersecurity, biotech, space tech, and hardware-enabled software. Typical initial checks are up to PLN 3M with follow-on capacity up to PLN 8M for top portfolio companies.
Biotech skincare startup developing bio-identical melanin from stem-cell-based processes to improve UV protection and skin health. The company focuses on long-duration photoprotection and alternatives to conventional sunscreen formulations.
Biotech drug-discovery company developing PKL-021, a small-molecule MMP inhibitor program for acute neuroprotection after stroke and traumatic brain injury, with additional applications in field-ready snakebite treatment.
Polish VC focused on deep tech and science-based companies, including industrial technology, advanced materials, and biotech. The fund follows a long-horizon approach for R&D-heavy ventures moving from lab to market.
Checking login status...
Loading comments...